Acura Pharmaceuticals Cash on Hand 2010-2021 | ACUR

Acura Pharmaceuticals cash on hand from 2010 to 2021. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Acura Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2021 $0
2020 $0
2019 $1
2018 $0
2017 $2
2016 $5
2015 $13
2014 $12
2013 $26
2012 $27
2011 $36
2010 $24
2009 $30
Acura Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $1
2020-03-31 $1
2019-12-31 $1
2019-09-30 $1
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $1
2018-03-31 $1
2017-12-31 $2
2017-09-30 $5
2017-06-30 $4
2017-03-31 $6
2016-12-31 $5
2016-09-30 $4
2016-06-30 $7
2016-03-31 $11
2015-12-31 $13
2015-09-30 $15
2015-06-30 $11
2015-03-31 $14
2014-12-31 $12
2014-09-30 $15
2014-06-30 $17
2014-03-31 $22
2013-12-31 $26
2013-09-30 $19
2013-06-30 $19
2013-03-31 $23
2012-12-31 $27
2012-09-30 $29
2012-06-30 $31
2012-03-31 $33
2011-12-31 $36
2011-09-30 $38
2011-06-30 $40
2011-03-31 $22
2010-12-31 $24
2010-09-30 $26
2010-06-30 $27
2010-03-31 $27
2009-12-31 $30
2009-09-30 $33
2009-06-30 $35
2009-03-31 $37
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.002B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.763B 5.69
Dr Reddy's Laboratories (RDY) India $12.496B 19.76
Aspen Pharmacare (APNHY) South Africa $5.583B 0.00
BridgeBio Pharma (BBIO) United States $5.256B 0.00
Bausch Health Cos (BHC) Canada $2.758B 2.10
Amphastar Pharmaceuticals (AMPH) United States $2.053B 14.27
Supernus Pharmaceuticals (SUPN) United States $1.672B 0.00
Taysha Gene Therapies (TSHA) United States $0.490B 0.00
Generation Bio (GBIO) United States $0.223B 0.00
Personalis (PSNL) United States $0.080B 0.00
Assembly Biosciences (ASMB) United States $0.070B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.023B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00